Virtu Financial LLC Caribou Biosciences, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$4.82 - $8.26 $315,912 - $541,376	65,542 Added 395.83%	82,100 $422,000
Q4 2023 Feb 26, 2024	SELL	$3.58 - $6.25 $59,037 - $103,068	-16,491 Reduced 49.9%	16,558 $95,000
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $134,839 - $269,018	33,049 New	33,049 $158,000
Q3 2022 Nov 07, 2022	BUY	$5.34 - $12.79 $7,326 - $17,547	1,372 Added 7.34%	20,067 $212,000
Q2 2022 Aug 09, 2022	BUY	$5.1 - $9.74 $95,344 - $182,089	18,695 New	18,695 $102,000
Q4 2021 Feb 17, 2022	SELL	$14.59 - $23.26 $189,961 - $302,845	-13,020 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$15.75 - $30.29 $205,065 - $394,375	13,020 New	13,020 $311,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $134M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.